Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysis
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.619344/full |
| _version_ | 1831591564642615296 |
|---|---|
| author | Rodrigo R. N. Rizzo Rodrigo R. N. Rizzo Michael A. Wewege Michael A. Wewege Hayley B. Leake Hayley B. Leake James H. McAuley James H. McAuley |
| author_facet | Rodrigo R. N. Rizzo Rodrigo R. N. Rizzo Michael A. Wewege Michael A. Wewege Hayley B. Leake Hayley B. Leake James H. McAuley James H. McAuley |
| author_sort | Rodrigo R. N. Rizzo |
| collection | DOAJ |
| first_indexed | 2024-12-18T01:27:31Z |
| format | Article |
| id | doaj.art-7843f6bafa5a43278c7e57e6d814dd74 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-12-18T01:27:31Z |
| publishDate | 2021-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-7843f6bafa5a43278c7e57e6d814dd742022-12-21T21:25:41ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-04-011210.3389/fphar.2021.619344619344Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysisRodrigo R. N. Rizzo0Rodrigo R. N. Rizzo1Michael A. Wewege2Michael A. Wewege3Hayley B. Leake4Hayley B. Leake5James H. McAuley6James H. McAuley7Centre for Pain IMPACT, Neuroscience Research Australia, Sydney, NSW, AustraliaSchool of Health Sciences, University of NSW, Sydney, NSW, AustraliaCentre for Pain IMPACT, Neuroscience Research Australia, Sydney, NSW, AustraliaSchool of Health Sciences, University of NSW, Sydney, NSW, AustraliaCentre for Pain IMPACT, Neuroscience Research Australia, Sydney, NSW, AustraliaIIMPACT in Health, University of SA, Adelaide, NSW, AustraliaCentre for Pain IMPACT, Neuroscience Research Australia, Sydney, NSW, AustraliaSchool of Health Sciences, University of NSW, Sydney, NSW, Australiahttps://www.frontiersin.org/articles/10.3389/fphar.2021.619344/fullanti-nerve growth factor antibodyosteoarthritis painchronic low-back painmeta-analysissystematic review |
| spellingShingle | Rodrigo R. N. Rizzo Rodrigo R. N. Rizzo Michael A. Wewege Michael A. Wewege Hayley B. Leake Hayley B. Leake James H. McAuley James H. McAuley Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysis Frontiers in Pharmacology anti-nerve growth factor antibody osteoarthritis pain chronic low-back pain meta-analysis systematic review |
| title | Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysis |
| title_full | Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysis |
| title_fullStr | Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysis |
| title_full_unstemmed | Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysis |
| title_short | Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysis |
| title_sort | commentary the efficacy of nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low back pain a meta analysis |
| topic | anti-nerve growth factor antibody osteoarthritis pain chronic low-back pain meta-analysis systematic review |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2021.619344/full |
| work_keys_str_mv | AT rodrigornrizzo commentarytheefficacyofnervegrowthfactorantibodyforthetreatmentofosteoarthritispainandchroniclowbackpainametaanalysis AT rodrigornrizzo commentarytheefficacyofnervegrowthfactorantibodyforthetreatmentofosteoarthritispainandchroniclowbackpainametaanalysis AT michaelawewege commentarytheefficacyofnervegrowthfactorantibodyforthetreatmentofosteoarthritispainandchroniclowbackpainametaanalysis AT michaelawewege commentarytheefficacyofnervegrowthfactorantibodyforthetreatmentofosteoarthritispainandchroniclowbackpainametaanalysis AT hayleybleake commentarytheefficacyofnervegrowthfactorantibodyforthetreatmentofosteoarthritispainandchroniclowbackpainametaanalysis AT hayleybleake commentarytheefficacyofnervegrowthfactorantibodyforthetreatmentofosteoarthritispainandchroniclowbackpainametaanalysis AT jameshmcauley commentarytheefficacyofnervegrowthfactorantibodyforthetreatmentofosteoarthritispainandchroniclowbackpainametaanalysis AT jameshmcauley commentarytheefficacyofnervegrowthfactorantibodyforthetreatmentofosteoarthritispainandchroniclowbackpainametaanalysis |